Skip Navigation LinksHome Page    >    Reduce risk for fetal anomalies before the pregnancy
Pregnancy links...
Health links...
Genetics links...
Medical links...
Autism links...
Other links...

Reduce risk for fetal anomalies before the pregnancy

Recommendations for investigation and treatment prior to pregnancy for reducing risks of defects or genetic diseases

  • Determination of the mother's immune status for a number of viruses or bacteria that may cause defects if she is infected with them during pregnancy.

  • Performing a test for carrier status of diseases such as Tay Sachs disease, Thallassemia in groups who tend to have a high frequency of the disease.

  • Performing tests using modern molecular methods for carrier status of other common severe genetic syndromes that are preventable (cystic fibrosis for example).

  • Taking prophylactic folic acid medication in order to reduce the risk for congenital defects in general, and for central nervous system and heart defects and cleft lip and palate in particular.


It is important to perform a number of blood tests to check whether the mother has immunity to those viruses and bacteria that are associated with causing fetal defects if she becomes infected during pregnancy. The pathogens in question, which are known by the acronym TORCHS, are Toxoplasma, Rubella (German measles), Cytomegalovirus, Herpes virus, and Syphilis. This is a blood test that is performed routinely during pregnancy, but doing it before pregnancy is advantageous.
  • If you are not immune to rubella, then even if you have been vaccinated in the past it is advisable to be vaccinated before pregnancy.
  • If tests show that you are not immune to toxoplasma, it is advisable to avoid contact with animals, especially dogs and cats. The information derived from these tests may also help to interpret with greater accuracy the results of blood tests performed during pregnancy in order to establish whether or not an infection has occurred during pregnancy.
  • Regarding cytomegalovirus and herpes virus, if you are not immune, it is important for you to monitor changes in antibody levels during your pregnancy. Here too, results of tests carried out before pregnancy are often important for the accurate interpretation of the results of blood tests performed during pregnancy in order to establish whether or not an infection has occurred during pregnancy.

Tay Sachs disease

This is a degenerative hereditary disease that is relatively common in Israel. It manifests as progressive brain degeneration that starts at the age of approximately 8 months in infants who develop normally up to that age.

The degeneration eventually leads to death at about the age of two.

Couples who are both carriers of the defective gene have a 25% risk in each pregnancy of having an affected child (see autosomal recessive inheritance).

This gene is common in Jews, especially those of Ashkenazi or North African origin.

However, it has also been reported in Jews from other ethnic groups.Carrier testing is therefore advisable for all couples considering pregnancy or when the woman is already pregnant, irrespective of ethnic origin.

The test has been carried out in Israel through the Ministry of Health for decades, and the number of patients in Israel has decreased significantly to almost zero.
To test for Tay Sachs disease, a blood test is carried out in which the level of the enzyme responsible for the disease is determined; in carriers, the level is decreased. The test is less reliable in pregnant women, so in these cases, or when a woman is taking birth control pills, it is best to refer her partner for testing. If the woman is not pregnant, she can undergo testing herself. In cases where one partner has been found to be a carrier, the other partner is asked to come for testing, and if both are found to be carriers they are invited to come for genetic counseling, during which it will be recommended that the mother undergo prenatal diagnosis in order to examine the fetus. Exact fetal diagnosis can be performed using chorionic villi or amniotic fluid cells. It is advisable to perform carrier testing before pregnancy, but it can also be done in the first weeks of gestation.

Molecular carrier screening

What is molecular screening?

Today, carrier status can be diagnosed for a number of genetic syndromes that are common in various ethnic groups. Since different diseases are common in different ethnic groups, it is important to consult your physician or genetic counselor and read the information about the various diseases in order to know what tests you should have done. Before deciding, it is important to ascertain the ethnic origins of both parents of each partner (including the birthplace of grandparents) in order to be able to recommend which tests should be performed.

When should testing be performed?

The tests should ideally be performed before pregnancy, but can also be done in the first weeks of gestation.

Preventive therapy: folic acid

Studies over the past 20 years have found that folic acid can help to reduce the frequency of open defects of the central nervous system. Subsequently it has also been found that this vitamin reduces the risk for cleft lip and palate and heart disorders. In studies of large populations of healthy subjects, it was found that administering folic acid with multivitamins significantly reduces the total risk for structural defects by about 35% or more. Therefore if the mother has no family history but has had a previous pregnancy with a fetus with defects of the types listed above, she should take multivitamins containing 0.4 mg or 0.8 mg folic acid. Another possibility is to take tablets containing only folic acid at a dose of 0.4 mg from about three months before pregnancy and for the first three months of gestation.
In cases where the mother is in a high-risk group for having a child with a defect of this kind, a small dose of multivitamins is insufficient. In these cases the recommended dosage is 4.5 mg folic acid a day for at least eight weeks before becoming pregnant through to the end of the first trimester of gestation. From the fourth month of pregnancy it is advisable for all women to take a combined iron (100 mg) and folic acid (0.5 mg) preparation.


Folic acid prevents these defects in 70% of cases; however it does not constitute an alternative to appropriate monitoring, genetic counseling, ultrasonic follow-up, alpha-fetoprotein testing within biochemical marker testing, or amniocentesis. These tests provide for diagnoses of defects in the fetus.
Haven't found what you're looking for? Search for it here:   
Comments (2)

Saturday, March 3, 2012 1:38 AM
(1) Justin Bieber Su  says:

very well

I was suggested this web site by way of my cousin. I am now not positive whether this post is written via him as no one else know such unique approximately my trouble. You are amazing! Thanks!

Thursday, December 6, 2012 7:58 AM
(2) sgeiu  says:


I came across this on the internet. I may return once again should you release further aricles

Leave a Comment
Email (will not be published)
Website (optional)
Your Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

Please type the characters you see in the picture:

All content Copyright © 2009-2011, Genetics of Pregnancy Encyclopedia Corporation. All rights reserved.